Pregnancy and risk of early breast cancer in carriers of BRCA1 and BRCA2

Lancet

Volumn 354, Issue 9193, 1999, Pages 1846-1850

  Jernstrom H ⁱ   Lerman, C ^a   Ghadirian, P ^b   Lynch, H T ^c   Weber, B ^d   Garber, J ^e   Daly, M ^f   Olopade, O I ⁱ   Foulkes, W D ^g   Warner, E ^h   Brunet, J S ⁱ   Narod, S A ⁱ  

^a GEORGETOWN UNIVERSITY   (United States)

^b CENTRE HOSPITALIER DE L UNIVERSITÉ DE MONTRÉAL   (Canada)

^c CREIGHTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d UNIVERSITY OF PENNSYLVANIA   (United States)

^e DANA FARBER CANCER INSTITUTE   (United States)

^f FOX CHASE CANCER CENTER   (United States)

^g MCGILL UNIVERSITY   (Canada)

^h DEPARTMENT OF RADIATION ONCOLOGY   (Canada)

ⁱ NONE

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGE; AGED; ARTICLE; BREAST CANCER; CASE CONTROL STUDY; CONTROLLED STUDY; FEMALE; GENE MUTATION; GENETIC COUNSELING; GENETIC SUSCEPTIBILITY; HUMAN; MAJOR CLINICAL STUDY; MATERNAL AGE; PARITY; PREGNANCY; PREGNANCY COMPLICATION; PRIORITY JOURNAL; QUESTIONNAIRE; RISK FACTOR;

EID: 0033610723     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(99)04336-6     Document Type: Article

References (30)

1. MacMahon B., Cole P., Lin T.M.et al. Age at first birth and breast cancer risk. Bull World Health Organ. 43:1970;209-221.
2. Kelsey J.L., Gammon M.D., John E.M. Reproductive factors and breast cancer. Epidemiol Rev. 15:1993;36-47.
3. Beral V., Reeves G. Childbearing, oral contraceptive use, and breast cancer. Lancet. 341:1993;1102.
4. Easton D.F., Ford D., Bishop D.T. Breast and ovarian cancer incidence in BRCA1-mutation carriers: the Breast Cancer Linkage Consortium. Am J Hum Genet. 56:1995;265-271.
5. Tonin P., Ghadirian P., Phelan C.et al. A large multisite cancer family is linked to, BRCA2. J Med Genet. 32:1995;982-984.
6. Struewing J.P., Hartge P., Wacholder S.et al. The risk of cancer associated with specific mutations of BRCA1 and BRCA2 among Ashkenazi Jews. N Engl J Med. 336:1997;1401-1408.
7. Narod S.A., Goldgar D., Cannon-Albright L.et al. Risk modifiers in carriers of BRCA1 mutations. Int J Cancer. 64:1995;394-398.
8. Ford D., Easton D.F., Stratton M.et al. Genetic heterogeneity and penetrance analysis of the BRCA1 and BRCA2 genes in breast cancer families: the Breast Cancer Linkage Consortium. Am J Hum Genet. 62:1998;676-689.
9. Johannsson O., Loman N., Borg A., Olsson H. Pregnancy-associated breast cancer in BRCA1 and BRCA2 germline mutation carriers. Lancet. 352:1998;1359-1360.
10. Lynch H.T., Albano W.A., Layton M.A., Kimberling W.J., Lynch J.F. Breast cancer, genetics, and age at first pregnancy. J Med Genet. 21:1984;96-98.
11. Colditz G.A., Rosner B.A., Speizer F.E. Risk factors for breast cancer according to family history of breast cancer. J Natl Cancer Inst. 88:1996;365-371.
12. Magnusson C., Colditz G., Rosner B., Bergstrom R., Persson I. Association of family history and other risk factors with breast cancer risk (Sweden). Cancer Causes Control. 9:1998;259-267.
13. McCredie M., Paul C., Skegg D.C., Williams S. Family history and risk of breast cancer in New Zealand. Int J Cancer. 73:1997;503-507.
14. Egan K.M., Stampfer M.J., Rosner B.A.et al. Risk factors for breast cancer in women with a breast cancer family history. Cancer Epidemiol Biomarkers Prev. 7:1998;359-364.
15. McCredie M.R., Dite G.S., Giles G.G., Hopper J.L. Breast cancer in Australian women under the age of 40. Cancer Causes Control. 9:1998;189-198.
16. Russo J., Russo I.H. Toward a physiological approach to breast cancer prevention. Cancer Epidemiol Biomarkers Prev. 3:1994;353-364.
17. Russo J., Tay L.K., Russo I.H. Differentiation of the mammary gland and susceptibility to carcinogenesis. Breast Cancer Res Treat. 2:1982;5-73.
18. Dickson R. Biochemical control of breast development. Harris J., Lippman M., Morrow M., Hellman S. Diseases of the breast. 1996;15-25.
19. Dickson R.B., Lippman M.E. Growth factors in breast cancer. Endocr Rev. 16:1995;559-589.
20. Russo J., Rivera R., Russo I.H. Influence of age and parity on the development of the human breast. Breast Cancer Res Treat. 23:1992;211-218.
21. Bassler R. The morphology of hormone induced structural changes in the female breast. Curr Top Pathol. 53:1970;1-89.
22. Preston-Martin S., Pike M.C., Ross R.K., Jones P.A., Henderson B.E. Increased cell division as a cause of human cancer. Cancer Res. 50:1990;7415-7421.
23. Fan S., Wang J., Yuan R.et al. BRCA1 inhibition of estrogen receptor signaling in transfected cells. Science. 284:1999;1354-1356.
24. Marquis S.T., Rajan J.V., Wynshaw-Boris A.et al. The developmental pattern of Brca1 expression implies a role in differentiation of the breast and other tissues. Nat Genet. 11:1995;17-26.
25. Rajan J.V., Wang M., Marquis S.T., Chodosh L.A. BRCA2 is coordinately regulated with BRCA1 during proliferation and differentiation in mammary epithelial cells. Proc Natl Acad Sci USA. 93:1996;13078-13083.
26. Jernström H., Johannsson O., Borg A., Olsson H Do BRCA1 mutations affect the ability to breast-feed?: significantly shorter length of breast feeding among BRCA1 mutation carriers compared with their unaffected relatives. Breast. 7:1998;320-324.
27. Russo J., Romero A.L., Russo I.H. Architectural pattern of the normal and cancerous breast under the influence of parity. Cancer Epidemiol Biomarkers Prev. 3:1994;219-224.
28. Russo J., Russo I.H. Toward a unified concept of mammary carcinogenesis. Prog Clin Biol Res. 396:1997;1-16.
29. Xu X., Wagner K.U., Larson D.et al. Conditional mutation of Brca1 in mammary epithelial cells results in blunted ductal morphogenesis and tumour formation. Nat Genet. 22:1999;37-43.
30. Gail M.H., Brinton L.A., Byar D.P.et al. Projecting individualized probabilities of developing breast cancer for white females who are being examined annually. J Natl Cancer Inst. 81:1989;1879-1886.